Harnessing glycobiology to direct the immune response
to treat cancer and inflammatory diseases


From discovery to breakthrough

Targeting glyco-immunology to unleash both innate and adaptive immune response to cancer

Our path to patient impact

Developing novel, first-in-class medicines to transform the treatment of cancer

Our team

We are driven to advance a completely new modality for cancer